Dingxie Liu

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Breast Cancer Cells

Endoplasmic Reticulum

Long Noncoding Rna

Electronic Health Record

Top Venues

Cellular oncology (Dordrecht)

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Dingxie Liu, Paul Hofman
Expression of NOTCH1, NOTCH4, HLA-DMA and HLA-DRA is synergistically associated with T cell exclusion, immune checkpoint blockade efficacy and recurrence risk in ER-negative breast cancer. Cellular oncology (Dordrecht) 45 (3) (2022)
Dingxie Liu, Jonathan Benzaquen, Luc G T Morris, Véronique Hofman, Paul Hofman
Mutations in KMT2C , BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer. Cancers 14 (11) (2022)
Dingxie Liu
Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers. Breast cancer research and treatment 183 (1) (2020)
Dingxie Liu
AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer. Cellular oncology (Dordrecht) 43 (2) (2020)
Dingxie Liu
Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis. Cellular oncology (Dordrecht) 42 (2) (2019)